When we look at how much money they make before expenses, they keep 0.872% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.295%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.294%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.112% return, is a testament to Regeneron Pharmaceuticals, Inc.'s adeptness in optimizing resource deployment. Regeneron Pharmaceuticals, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.151%. Furthermore, the proficiency of Regeneron Pharmaceuticals, Inc. in capital utilization is underscored by a remarkable 0.125% return on capital employed.
Stock Prices
Regeneron Pharmaceuticals, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $913.21, while its low point bottomed out at $888.52. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Regeneron Pharmaceuticals, Inc.'s stock market.
Liquidity Ratios
Analyzing REGN liquidity ratios reveals its financial health of the firm.
The current ratio of 527.00% gauges short-term asset coverage for liabilities.
The quick ratio (439.60%) assesses immediate liquidity, while the cash ratio (72.66%) indicates cash reserves.
cards.indicator
cards.value
Current Ratio
527.00%
Quick Ratio
439.60%
Cash Ratio
72.66%
Profitability Ratios
REGN profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 30.85% underscores its earnings before tax deductions.
The effective tax rate stands at 4.56%, revealing its tax efficiency.
The net income per EBT, 95.44%, and the EBT per EBIT, 104.74%, provide insights into its earnings hierarchy.
Lastly, with an EBIT per revenue ratio of 29.46%, we grasp its operational profitability.
cards.indicator
cards.value
Pretax Profit Margin
30.85%
Effective Tax Rate
4.56%
Net Income per EBT
95.44%
EBT per EBIT
104.74%
EBIT per Revenue
29.46%
Operational Efficiency
Operational metrics shed light on its business agility. With an operating cycle of 5.27, it details the span from stock purchase to revenue.
The 4 days it takes to settle debts showcases its creditor relations.
Meanwhile, a 1 cash conversion cycle and 250.85% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.
cards.indicator
cards.value
Days of Sales Outstanding
440
Days of Inventory Outstanding
589
Operating Cycle
734.75
Days of Payables Outstanding
146
Cash Conversion Cycle
589
Receivables Turnover
2.51
Payables Turnover
2.51
Inventory Turnover
0.62
Fixed Asset Turnover
3.10
Asset Turnover
0.38
Cash Flow Ratios
Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 43.96, and free cash flow per share, 36.87, depict cash generation on a per-share basis.
The cash per share value, 97.58, showcases liquidity position.
Lastly, the operating cash flow sales ratio, 0.36, offers insight into cash flow relative to sales.
cards.indicator
cards.value
Operating Cash Flow per Share
43.96
Free Cash Flow per Share
36.87
Cash per Share
97.58
Operating Cash Flow Sales Ratio
0.36
Free Cash Flow to Operating Cash Flow Ratio
0.84
Cash Flow Coverage Ratio
2.39
Short Term Coverage Ratio
4738900000.00
Capital Expenditure Coverage Ratio
6.20
Dividend Paid and Capex Coverage Ratio
6.20
Debt and Leverage Ratios
Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 5.77%, highlights its total liabilities relative to assets.
With a debt-equity ratio of 0.07, we discern the balance between debt and equity financing.
The long-term debt to capitalization, 6.85%, and total debt to capitalization, 6.85%, ratios shed light on its capital structure.
An interest coverage of 108.70 indicates its ability to manage interest expenses.
cards.indicator
cards.value
Debt Ratio
5.77%
Debt Equity Ratio
0.07
Long Term Debt to Capitalization
6.85%
Total Debt to Capitalization
6.85%
Interest Coverage
108.70
Cash Flow to Debt Ratio
2.39
Company Equity Multiplier
1.27
Per Share Data
Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 122.94, provides a glimpse into top-line earnings distributed across each share.
Net income per share, 37.05, reflects the portion of profit attributed to each share.
The book value per share, 243.42, represents the net asset value distributed per share, while the tangible book value per share, 233.69, excludes intangible assets.
cards.indicator
cards.value
Revenue Per Share
122.94
Net Income Per Share
37.05
Book Value Per Share
243.42
Tangible Book Value Per Share
233.69
Shareholders Equity Per Share
243.42
Interest Debt Per Share
26.02
Capex Per Share
-8.68
Growth Ratios
Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 7.76%, indicates top-line expansion, while the gross profit growth, 6.49%, reveals profitability trends.
EBIT growth, -14.60%, and operating income growth, -14.60%, offer insights into operational profitability progression.
The net income growth, -8.87%, showcases bottom-line expansion, and the EPS growth, -8.54%, measures the growth in earnings per share.
cards.indicator
cards.value
Revenue Growth
7.76%
Gross Profit Growth
6.49%
EBIT Growth
-14.60%
Operating Income Growth
-14.60%
Net Income Growth
-8.87%
EPS Growth
-8.54%
EPS Diluted Growth
-9.03%
Weighted Average Shares Growth
-0.37%
Weighted Average Shares Diluted Growth
0.18%
Operating Cash Flow Growth
-8.39%
Free Cash Flow Growth
-17.11%
10-Year Revenue Growth per Share
549.62%
5-Year Revenue Growth per Share
110.30%
3-Year Revenue Growth per Share
55.67%
10-Year Operating CF Growth per Share
713.56%
5-Year Operating CF Growth per Share
125.17%
3-Year Operating CF Growth per Share
76.95%
10-Year Net Income Growth per Share
871.12%
5-Year Net Income Growth per Share
74.02%
3-Year Net Income Growth per Share
13.48%
10-Year Shareholders Equity Growth per Share
1286.90%
5-Year Shareholders Equity Growth per Share
219.10%
3-Year Shareholders Equity Growth per Share
137.56%
Receivables Growth
6.35%
Inventory Growth
7.44%
Asset Growth
13.23%
Book Value per Share Growth
15.03%
Debt Growth
0.06%
R&D Expense Growth
23.56%
SGA Expenses Growth
24.36%
Other Metrics
Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 93,686,443,000, captures the company's total value, considering both debt and equity.
Income quality, 1.16, assesses the reliability of reported earnings.
The ratio of intangibles to total assets, 3.14%, indicates the value of non-physical assets, and capex to operating cash flow, -20.17%, measures reinvestment capability.
cards.indicator
cards.value
Enterprise Value
93,686,443,000
Income Quality
1.16
Research and Development to Revenue
33.84%
Intangibles to Total Assets
3.14%
Capex to Operating Cash Flow
-20.17%
Capex to Revenue
-7.06%
Capex to Depreciation
-220.05%
Stock-Based Compensation to Revenue
6.75%
Graham Number
450.49
Return on Tangible Assets
12.34%
Graham Net Net
86.96
Working Capital
16,055,800,000
Tangible Asset Value
24,934,500,000
Net Current Asset Value
12,372,100,000
Average Receivables
5,498,000,000
Average Payables
597,900,000
Average Inventory
2,491,200,000
Days Sales Outstanding
158
Days Payables Outstanding
122
Days of Inventory On Hand
519
ROIC
13.29%
ROE
0.15%
Valuation Ratios
Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 3.87, and the price to book ratio, 3.87, reflect the market's valuation relative to the company's book value.
The price to sales ratio, 8.01, provides a perspective on valuation in relation to sales.
Ratios like price to free cash flows, 26.39, and price to operating cash flows, 22.02, gauge market valuation against cash flow metrics.
cards.indicator
cards.value
Price Book Value Ratio
3.87
Price to Book Ratio
3.87
Price to Sales Ratio
8.01
Price Cash Flow Ratio
22.02
Price Earnings to Growth Ratio
0.30
Enterprise Value Multiple
23.54
Price Fair Value
3.87
Price to Operating Cash Flow Ratio
22.02
Price to Free Cash Flows Ratio
26.39
Price to Tangible Book Ratio
3.61
Enterprise Value to Sales
7.14
Enterprise Value Over EBITDA
18.26
EV to Operating Cash Flow
20.39
Earnings Yield
4.22%
Free Cash Flow Yield
3.91%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
